Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
61 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Adelaide Hospital-Hospital
Adelaide, South Australia, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- Medizinische Univ.-Kliniken Graz-Hospital
Graz, Austria
- St. Jan
Bruges, Belgium
- Hamilton General Hospital
Hamilton, Ontario, Canada
- Institut Universitaire de Cardiologie Et de Pneumologie de Quebec
Québec, Quebec, Canada
- Klinicki Bolnicki Centar Split
Split, Croatia
- Chu Grenoble - Hopital Michallon
Grenoble, France
- Cardioangiologisches Centrum Bethanien
Frankfurt, Germany
- Staedtisches Klinikum Karlsruhe
Karlsruhe, Germany
- Queen Mary Hospital
Hong Kong, Hong Kong
- Prince of Wales Hospital
Shatin, Hong Kong
- Aou Delle Marche - Po Gm Lancisi
Ancona, AN, Italy
- Centro Cardiologico Monzino
Milan, MI, Italy
- Maria Cecilia Hospital Spa
Cotignola, RA, Italy
- Fondazione Ptv - Policlinico Tor Vergata
Roma, Italy
- National Heart Centre Singapore
Singapore, Singapore
- Hospital Universitario la Fe
Valencia, Spain
- Taipei Veterans General Hospital-Hospital
Taipei, Taiwan
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Banner University Medical Center Phoenix
Phoenix, Arizona, United States
- Phoenix Cardiovascular Research Group
Phoenix, Arizona, United States
- Arrhythmia Research Group
Jonesboro, Arkansas, United States
- Scripps Memorial Hosptial
La Jolla, California, United States
- Stanford University Medical Center
Palo Alto, California, United States
- Cardiology Associates Medical Group, Inc
Ventura, California, United States
- Hca Florida Mercy Hospital
Miami, Florida, United States
- Sarasota Memorial Hospital
Sarasota, Florida, United States
- Tallahassee Memorial Hospital
Tallahassee, Florida, United States
- St. Joseph'S Hospital
Tampa, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- St. John'S Hospital
Springfield, Illinois, United States
- Community Heart and Vascular Hospital
Indianapolis, Indiana, United States
- Mercy Hospital Medical Center-Hospital
West Des Moines, Iowa, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Southcoast Physicians Group
Fall River, Massachusetts, United States
- University of Michigan Hospitals
Ann Arbor, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Dec 2023
- Primary completion
- 4 Feb 2026
- Completion
- 4 Feb 2028
- Last update posted
- 30 Jun 2026
- Registered enrollment
- 484
- Registry id
- NCT06096337
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.